Amundi Asset Management US’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$13.5M Sell
276,829
-39,452
-12% -$1.85M 0.01% 767
2020
Q4
$12.8M Buy
316,281
+10,635
+3% +$380K 0.01% 743
2020
Q3
$9.94M Sell
305,646
-12,043
-4% -$362K 0.01% 740
2020
Q2
$8.38M Buy
317,689
+116,086
+58% +$3.03M 0.01% 749
2020
Q1
$1.64M Buy
201,603
+38,409
+24% +$1.19M ﹤0.01% 1002
2019
Q4
$5.86M Buy
163,194
+8,305
+5% +$287K 0.01% 865
2019
Q3
$5.3M Buy
154,889
+69,585
+82% +$2.22M 0.01% 849
2019
Q2
$17.6M Buy
+85,304
New +$2.37M 0.01% 624

Other funds holding LMAT

Amundi Asset Management US's LMAT Position: Q1 2021 in Review

Amundi Asset Management US reduced its LeMaitre Vascular (LMAT) stake by 12% in Q1 2021, selling an estimated $1.85M and leaving 276,829 shares worth $13.5M. The position accounts for 0.01% of the portfolio, ranked #767.

Amundi Asset Management US first reported a position in LMAT in Q2 2019 and has held it in 8 quarters since. The position peaked at $17.6M in Q2 2019. 179 funds tracked by Wall St. Rank hold LMAT as of Q1 2021.

  • Amundi Asset Management US held 276,829 shares of LeMaitre Vascular worth $13.5M as of Q1 2021.
  • Amundi Asset Management US sold 39,452 LeMaitre Vascular shares in Q1 2021, an estimated $1.85M.
  • LeMaitre Vascular made up 0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #767 holding.
  • Amundi Asset Management US first reported a position in LeMaitre Vascular in Q2 2019 and has held it in 8 quarters since.
  • Amundi Asset Management US's LeMaitre Vascular position peaked at $17.6M in Q2 2019.
  • 179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.